Oxifyl Tablet

About Oxifyl 400 mg Tablet

Oxifyl is a 400 mg tablet made by Square Pharmaceuticals PLC. It contains pentoxifylline, a peripheral vasodilator prescribed for circulation problems such as intermittent claudication and other circulatory disorders.

There are 4 brands of Pentoxifylline listed in Bangladesh. The lowest listed price is Trental 400 mg Tablet at ৳ 15.11 per unit.

What is Oxifyl 400 mg Tablet?

Oxifyl 400 mg tablet is a prescription medicine from Square Pharmaceuticals PLC. Its active ingredient is pentoxifylline, which belongs to a group of peripheral vasodilator medicines. It works by making the blood flow more easily through small blood vessels, which can help blood reach affected areas of the body. Doctors prescribe it for peripheral arterial occlusive disease of arteriosclerotic or diabetic origin, including intermittent claudication and rest pain. It is also used for trophic lesions such as leg ulcers and gangrene, for cerebral vascular diseases, and for circulatory disturbances of the eye linked with degenerative vascular disorders. The doctor decides whether it suits a particular patient.

Uses of Oxifyl

Oxifyl is used for peripheral arterial occlusive disease caused by arteriosclerosis or diabetes, including intermittent claudication and rest pain. It is also prescribed for trophic lesions such as leg ulcers and gangrene, for cerebral vascular diseases, and for circulatory disturbances of the eye connected with degenerative vascular disorders. Only a registered physician should decide whether this medicine is appropriate, and for what purpose, in an individual case.

How to use Oxifyl

Oxifyl tablets are swallowed whole, not chewed or crushed, during or shortly after a meal with a sufficient amount of liquid. The doctor sets the dose and how long it is taken, based on the type and severity of the circulatory disorder and on how well each patient tolerates the medicine. Do not change the dose or stop the course on your own; ask the doctor or pharmacist if you are unsure about anything.

Side effects of Oxifyl

Reported side effects include nausea, vomiting, gastric pressure, abdominal fullness, dizziness, headache, and a fall in blood pressure. Heart-related effects such as irregular heartbeat, fast heartbeat and angina pectoris have been reported, as have increases in liver transaminases and changes in blood cell counts. Aseptic meningitis has also been reported. If you notice any unusual symptom, contact your doctor promptly; the doctor will advise whether to continue the medicine.

Safety and precautions

Do not use Oxifyl if you are allergic to pentoxifylline, other methylxanthines, or any ingredient of the tablet, or if you have massive bleeding or extensive retinal bleeding. Tell your doctor before use if you have severe heart rhythm problems, have had a heart attack, have low blood pressure, impaired kidney or liver function, or increased bleeding. Careful monitoring is needed with anti-vitamin K drugs, platelet aggregation inhibitors, diabetes medicines and blood-pressure-lowering drugs. It is not recommended in pregnancy, and in breastfeeding the doctor must weigh risks and benefits. Ask your doctor first in all these situations.

Frequently asked questions

What kind of medicine is Oxifyl and what is it used for?

Oxifyl is a peripheral vasodilator tablet containing pentoxifylline. It is prescribed for peripheral arterial occlusive disease such as intermittent claudication and rest pain, for leg ulcers and gangrene, for cerebral vascular diseases, and for certain circulatory disturbances of the eye.

Who should avoid Oxifyl or ask the doctor first?

People allergic to pentoxifylline, other methylxanthines or the tablet's ingredients, and those with massive bleeding or extensive retinal bleeding, must not use it. Ask the doctor first if you have heart rhythm problems, have had a heart attack, low blood pressure, kidney or liver problems, or a bleeding tendency.

What does the generic name pentoxifylline mean?

Pentoxifylline is the generic name of the active substance in Oxifyl. It belongs to the methylxanthine group and is classed as a peripheral vasodilator. It is thought to improve blood flow by lowering blood viscosity, but your doctor can explain more about how it is expected to help you.

Can I take Oxifyl with my other medicines?

Some medicines need extra care with Oxifyl, including anti-vitamin K drugs, platelet aggregation inhibitors, diabetes medicines and blood-pressure-lowering drugs. Tell your doctor and pharmacist about everything you take, and do not start or stop any medicine without their advice.

Indications

This is indicated in-
  • Peripheral arterial occlusive disease (PAOD) of arteriosclerotic or diabetic origin (e.g. with intermittent claudication and rest pain)
  • Trophic lesions (e.g. leg ulcers and gangrene)
  • Cerebral vascular diseases 
  • Circulatory disturbances of the eye in conjunction with degenerative vascular disorders.

Pharmacology

Pentoxifylline and its metabolites improve the flow properties of blood by decreasing its viscosity. In patients with chronic peripheral arterial disease, this increases blood flow to the affected microcirculation and enhances tissue oxygenation. The precise mode of action of pentoxifylline and the sequence of events leading to clinical improvement are still to be defined. Pentoxifylline administration has been shown to produce dose-related hemorrheologic effects, lowering blood viscosity, and improving erythrocyte flexibility. Leukocyte properties of hemorrheologic importance have been modified in animal and in vitro human studies. Pentoxifylline has been shown to increase leukocyte deformability and to inhibit neutrophil adhesion and activation. Tissue oxygen levels have been shown to be significantly increased by therapeutic doses of pentoxifylline in patients with peripheral arterial disease.

Dosage & Administration

In principle, dosage is based on the type and severity of the circulatory disorders and on how the individual patient tolerates the drug. Usual dosage is 400 mg pentoxifylline 2 to 3 times daily. Tablets are to be swallowed whole during or shortly after a meal with sufficient amounts of liquid (approx. ½ glass).

Interaction

  • Precautions for use: The blood-sugar-lowering effect of insulin or oral antidiabetics may be potentiated. Therefore it is recommended that patients under medication for diabetes mellitus be carefully monitored. Post-marketing cases of increased anti-coagulant activity have been reported in patients concomitantly treated with pentoxifylline and anti-vitamin K. Monitoring of anti-coagulant activity in these patients is recommended when pentoxifylline is introduced or the dose is changed.
  • Take into account: The blood-pressure-lowering efect of antihypertensive agents and other drugs with blood-pressure-lowering potential may be increased by Pentoxifylline.
  • Concomitant administration of pentoxifylline and theophylline may increase theophylline levels in some patients. Therefore, there may be an increase in and intensifcation of adverse reactions from theophylline.
  • Concomitant administration with ciprofoxacin may increase the serum concentration of pentoxifylline in some patients. Therefore, there may be an increase in and intensifcation of adverse reactions associated with co-administration.
  • Potential additive efect with platelet aggregation inhibitors: Because of the increased risk of bleeding, the concomitant administration of a platelet aggregation inhibitor (such as clopidogrel, eptifibatide, tirofiban, epoprostenol, iloprost, abciximab, anagrelide, NSAIDs other than selective COX-2 inhibitors, acetylsalicylates [ASA/LAS], ticlopidine, dipyridamole) with pentoxifylline should be undertaken with caution.
  • Concomitant administration with cimetidine may increase the plasma concentration of pentoxifylline and the active Metabolite.

Contraindications

Pentoxifylline must not be used:
  • in patients with hypersensitivity to pentoxifylline, other methylxanthines or any of the excipients of Pentoxifylline.
  • in patients with massive bleeding (risk of increased bleeding).
  • in patients with extensive retinal bleeding (risk of increased bleeding).

Side Effects

These adverse reactions have been reported in clinical trials or post-marketing-
  • Investigations: Transaminases increased (Transaminase elevation), Blood pressure decreased (Fall in blood pressure)
  • Cardiac disorders: Arrhythmia (Cardiac arrhythmia), Tachycardia, Angina Pectoris
  • Blood and lymphatic system disorders: Thrombocytopenia (Thrombopenia), Leucopenia/neutropenia
  • Nervous system disorders: Dizziness, headache, meningitis aseptic (Aseptic meningitis)
  • Gastrointestinal disorders: Gastrointestinal disorder (Gastrointestinal complaints), Epigastric discomfort (Gastric pressure), Abdominal distension (Fullness), Nausea, Vomiting, Diarrhoea, Constipation, Hypersalivation
  • Skin and subcutaneous tissue disorders: Pruritus, Erythema (Reddening of the skin), Urticaria, Rash
  • Vascular disorders: Hot fush (Flushes), Haemorrhage (Bleedings)
  • Immune system disorders: Anaphylactic reaction, Anaphylactoid reaction, Angioedema (Angioneurotic edema), Bronchospasm, Anaphylactic shock (shock)
  • Hepatobiliary disorders: Cholestasis (Intrahepatic cholestasis)
  • Psychiatric disorders: Agitation, Sleep disorder (Sleep disturbances)

Pregnancy & Lactation

Insufficient experience has been gained concerning use in pregnancy. Therefore, it is recommended that Pentoxifylline is not used during pregnancy. Pentoxifylline passes into breast milk in minute quantities. Because insufficient experience has been gained, the physician must carefully weigh the possible risks and benefits before administering Pentoxifylline in breast-feeding women.

Precautions & Warnings

At the first signs of an anaphylactic/anaphylactoid reaction, Pentoxifylline must be discontinued or the infusion be halted immediately, and a physician must be informed. Particularly careful monitoring is required:
  • in patients with severe cardiac arrhythmias
  • in patients with myocardial infarction
  • in hypotensive patients
  • in patients with impaired renal function (creatinine clearance below 30 ml/min)
  • in patients with severely impaired liver function
  • in patients with increased bleeding
  • in patients treated concomitantly with pentoxifylline and anti-vitamin K or platelet aggregation inhibitors
  • in patients treated concomitantly with pentoxifylline and antidiabetic agents
  • in patients treated concomitantly with pentoxifylline and ciprofoxacin
  • in patients treated concomitantly with pentoxifylline and theophylline

Overdose Effects

Initial symptoms of acute overdose with pentoxifylline may be nausea, dizziness, tachycardia or a fall in blood pressure. Furthermore, signs such as fever, agitation, flush, loss of consciousness, areflexia, tonic -clonic convulsions and as a sign of gastrointestinal bleeding - coffee-ground vomiting may occur. No specific antidote is known. If ingestion has only just taken place, attempts may be made to prevent further systemic absorption of the active ingredient by primary elimination of the toxin (e.g. gastric lavage) or by delaying its absorption (e.g. activated charcoal).

Storage Conditions

Keep in a cool and dry place, away from light. Do not use later than date of expiry. Keep all medicine out of the reach of children. To be dispensed only on the prescription of a registered physician.

Alternative brands of Pentoxifylline

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.